Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression
about
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessFunctional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells.Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.Molecular genetics of Müllerian duct formation, regression and differentiationFocal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchymeCancer stem cells as targets for cancer therapy: selected cancers as examples.Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.β-Catenin is essential for Müllerian duct regression during male sexual differentiation.The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens.Normal and abnormal epithelial differentiation in the female reproductive tract.Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerc-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristicsPartial Müllerian Duct Retention in Smad4 Conditional Mutant Male MiceMolecular analysis of the beta-catenin gene in patients with the Mayer-Rokitansky-Küster-Hauser syndrome.Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survivalCellular mechanisms of Müllerian duct formation in the mouse.Endocrine disruptors in female reproductive tract development and carcinogenesis.Lhx1 is required in Müllerian duct epithelium for uterine development.When hormone defects cannot explain it: malformative disorders of sex development.The TGF-β Family in the Reproductive Tract.Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.siRNA as a tool for investigating organogenesis: The pitfalls and the promises.Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development.The mechanisms underlying the effects of AMH on Müllerian duct regression in male mice.Identification and characterization of an R-Smad ortholog (SmSmad1B) from Schistosoma mansoni.
P2860
Q33250633-D4CDE919-6115-4872-AF88-CCDC2346533BQ33621021-7260AF52-2F92-4E34-825D-6E71D8E96815Q33682524-67ABFEF9-4E85-412F-8181-A8B81D0D7F8BQ33719519-89BFB7FA-4AFB-44D9-BD0B-01C01ACA0DC0Q34041473-28AE0B53-C17A-4BA3-AEB4-AD331D7F66E2Q34136372-80F08BFB-970D-4CF3-A6E8-3473E16F7AEDQ34199130-69D4FDCB-F3D3-4FF6-A71D-6161C0F98460Q34434627-6CC5A4A1-277F-495C-92D3-F1C63657A3BEQ34855908-877C1F69-E308-4486-85A7-6557E9CDAB59Q35070724-E4E5C445-E9B7-4DB8-82B0-69F78B469D1CQ35226585-77347629-69FB-4061-AB80-0533090A08E1Q35768666-B008E8D1-3508-4C02-8850-5A780C920F2EQ35787316-A5DAF35A-A812-4F03-8000-D1C878EDC542Q35857103-65238C7D-CB23-4C38-B2C5-A4F5AA2FD8DFQ35961381-DDFF7B66-F4D6-4AC4-839B-7D702C7CBC05Q36372596-1E1AE72E-6DB7-45F3-84AE-F39721D30A27Q36421055-3883447E-1B58-482A-815F-4DCE51D94469Q36637142-86BE453B-9BFC-4591-92E6-3370535736C6Q36858621-DB563A67-CF91-4412-93C1-8F6E31D5D92DQ36911079-5A120711-B672-4C30-A749-1283C586508FQ36995787-C562E03E-AB7B-4C82-A66F-A532BE531348Q37125897-2104040D-AFD7-4BAE-8178-3D3B1F87419BQ37315327-FB41A40B-2D82-4B6D-ADF7-82E3B81676EDQ37415449-ACAFCCE3-1362-4599-9F3B-9D9B445E726DQ37705585-219C7DCA-A944-46A3-8981-4CD986C2D872Q38282798-9D61D5A5-1553-4F70-A61B-4C558E96AE30Q38963328-7D27124E-ADED-4E63-81AC-A4290E803582Q41979395-E4580A7A-5922-4C5D-85D7-996903496FC8Q42097337-82FFD946-0BA9-4607-95EF-9C7858D2B72BQ50480505-FDFD995F-3C38-40A0-A5F7-293D33D76038Q51734783-B0533041-C39D-44A9-99FC-868A621A9DD1Q51745983-A5981CB5-6C61-4B27-A8EF-1165A8B7AF17
P2860
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression
description
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/06/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/06/01)
@nl
наукова стаття, опублікована в червні 2006
@uk
مقالة علمية (نشرت في يونيو 2006)
@ar
name
Müllerian inhibiting substance ...... y in Müllerian duct regression
@ast
Müllerian inhibiting substance ...... y in Müllerian duct regression
@en
Müllerian inhibiting substance ...... y in Müllerian duct regression
@nl
type
label
Müllerian inhibiting substance ...... y in Müllerian duct regression
@ast
Müllerian inhibiting substance ...... y in Müllerian duct regression
@en
Müllerian inhibiting substance ...... y in Müllerian duct regression
@nl
prefLabel
Müllerian inhibiting substance ...... y in Müllerian duct regression
@ast
Müllerian inhibiting substance ...... y in Müllerian duct regression
@en
Müllerian inhibiting substance ...... y in Müllerian duct regression
@nl
P2093
P3181
P356
P1433
P1476
Müllerian inhibiting substance ...... y in Müllerian duct regression
@en
P2093
Akihiro Fujino
David T MacLaughlin
Nelson A Arango
Patricia K Donahoe
Paul P Szotek
Thomas F Manganaro
P304
P3181
P356
10.1242/DEV.02383
P407
P577
2006-05-10T00:00:00Z